Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/31/2025

Management of Low Alkaline Phosphatase with Unexplained Fracture

Initial Diagnostic Workup

  • A patient presenting with low alkaline phosphatase and unexplained fracture should be evaluated for hypophosphatasia through measurement of serum pyridoxal 5'-phosphate (vitamin B6), urinary phosphoethanolamine, and genetic testing for ALPL gene mutations, as this diagnosis fundamentally changes management by contraindicating standard osteoporosis treatments like bisphosphonates 1
  • Serum PTH and 25(OH) vitamin D levels should be checked to exclude other metabolic bone disorders, according to the American Society of Nephrology 2

Critical Differential Diagnosis Considerations

  • The differential diagnosis of hypophosphatasia (childhood type) presents with premature tooth loss, rachitic bone changes, fractures, and undermineralization, requiring urinary phosphoethanolamine, plasma ALP, and TNSALP gene testing, as recommended by the American College of Medical Genetics 1
  • X-linked hypophosphatemia presents with hypophosphatemia, elevated (not low) ALP, and elevated FGF23, according to the National Kidney Foundation 3

Management Approach

  • Discontinue antiresorptive therapy immediately, as bisphosphonates, denosumab, and other antiresorptive drugs are contraindicated in hypophosphatasia and may worsen symptoms, as stated by the American Society of Bone and Mineral Research 1

Important Clinical Pitfalls

  • Persistently low ALP (on majority of measurements) is the key finding that warrants full hypophosphatasia workup, according to the Endocrine Society 1
  • Referral to an endocrinologist or metabolic bone disease specialist is indicated for unexpectedly low ALP levels with fractures, young age at presentation with fragility fractures, recurrent fractures despite treatment, or confirmed or suspected hypophosphatasia requiring enzyme replacement therapy, as recommended by the Mayo Clinic 4

Diagnostic Criteria and Differential Diagnosis for Hypophosphatasia

Laboratory Markers

  • Urinary phosphoethanolamine (PEA) elevation supports the diagnosis of hypophosphatasia, although it is less reliable than serum pyridoxal‑5′‑phosphate; plasma ALP and urinary PEA are specifically recommended when evaluating childhood‑type disease. 5

Age‑Specific Clinical Features

  • Severe undermineralization and bone deformities on radiographs are characteristic in the perinatal/infantile presentation of hypophosphatasia. 5
  • Premature loss of fully rooted primary teeth is a hallmark of the childhood form. 5
  • Rachitic‑type bone changes accompanied by fractures are commonly observed in children with hypophosphatasia. 5
  • Generalized bone undermineralization on imaging is typical in pediatric patients. 5

Radiographic Evaluation

  • Skeletal radiographs should be obtained to identify characteristic findings such as undermineralization, fractures, and rachitic changes when hypophosphatasia is suspected. 5

Differential Diagnosis Considerations

  • Osteogenesis imperfecta usually presents with normal or elevated alkaline phosphatase; confirmation requires COL1A1/COL1A2 genetic testing. 5
  • Non‑accidental injury must be excluded, as hypophosphatasia can be mistakenly attributed to abuse in infants with unexplained fractures. 5
  • Persistent blue sclera beyond infancy warrants pathologic investigation because it may indicate an underlying bone disorder. 5
  • In infants with fractures, biochemical testing (e.g., low ALP, elevated PLP) or DNA analysis is often necessary to differentiate hypophosphatasia from other causes. 5